Favipiravir at high doses has potent antiviral activity in SARS-CoV-2-infected hamsters, whereas hydroxychloroquine lacks activity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: 2020-10-27

DOI: 10.1073/pnas.2014441117

Affiliations: 13

Authors: 35

Go to article
Institutions Share
Catholic University of Leuven (KU Leuven), Belgium 0.64
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium 0.10
UCL, United Kingdom (UK) 0.09
Emerging Viral Diseases (EPV), France 0.03
Ghent University Hospital, Belgium 0.03
Division of Nuclear Medicine - Nuclear Medicine and Molecular Imaging, KU Leuven, Belgium 0.03
Emerging Viral Diseases Unit (UVE), France 0.03
Laboratory of Translational Cell and Tissue Research, KU Leuven, Belgium 0.03
University Hospitals Leuven (UZ Leuven), Belgium 0.01
Global Virus Network (GVN), United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER